
Pharmacy
Patients with Newly Diagnosed Mantle Cell Lymphoma Have Improved Progression-Free Survival When Taking Ibrutinib and Chemo-Immunotherapy
For previously untreated mantle cell lymphoma (MCL) in patients 65 and older, combination chemotherapy with the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free…










